Rocket Lab’s selloff looks like an opportunity, not a warning, if the real lens here is defense and space infrastructure. The business is growing fast enough to justify a premium story, with revenue up 38.0% year over year to $601.8 million, and the strategic shift is getting harder to ignore. A company that just proved rapid-response mission execution for the U.S. Space Force and locked in meaningful HASTE defense work should not be framed as just another volatile launch stock. We think the market is still catching up to what RKLB is becoming.
The cleanest reason to stay bullish is that Rocket Lab now has real evidence behind the platform narrative. The proposed roughly $8 billion Iridium acquisition would turn the company into a more vertically integrated operator across design, build, launch, and constellation ownership, which is a much bigger and stickier model than selling launch slots alone. That strategic move matters more than a one-day price drop because it expands Rocket Lab’s role in the space stack rather than just adding volume to an existing niche.
The defense angle is no longer theoretical. Rocket Lab secured a $190 million contract for 20 HASTE launches under MACH-TB 2.0 and added a separate $30 million HASTE contract from Anduril for three hypersonic test launches. Then it followed that with the July 7 VICTUS HAZE mission success, completing a Space Force-related launch and on-orbit tracking mission in record time. That combination is exactly what defense customers pay up for: not just hardware, but responsiveness and execution under mission pressure.
The financial profile is still early-stage, but the growth engine is real. Revenue growth of 38.0% stands out in an aerospace group where peers like HEICO grew 16.3%, Wabtec grew 7.5%, and Verisk grew 6.6%. Rocket Lab’s TickerSpark Score tells the same story in a more balanced way: Growth scores 70 and Financial Health scores 84, even while Valuation sits at 20 and Profitability at 35. That is the signature of a company being priced for what it could become, and in this case the business developments support that re-rating rather than undermine it.
The obvious pushback is valuation, and it is a fair one. RKLB trades at 57.37 times sales, carries a negative operating margin of 33.2%, and sits well below its 50-day and 200-day moving averages after a brutal reset from a 52-week high of 151. The technical picture is weak, the TickerSpark Score is only 48 overall, and insider selling has been heavy, with 986,197 shares sold for $94.02 million across the last 10 reported transactions.
That risk is real, but it does not break the bull case because the market is not being asked to fund a stagnant concept stock. Consensus still leans positive with 15 buys against 4 holds and 1 sell, news sentiment remains strongly positive, and the strategic milestones are tangible rather than promotional. The stock is expensive because the market sees a path to a much larger business; the recent drop simply means investors are getting that thesis after a sentiment washout instead of at peak enthusiasm.
What matters now is whether Rocket Lab keeps proving it can execute the defense-and-infrastructure playbook faster than the market can discount it. We would watch Neutron development updates, Iridium deal milestones expected toward a mid-2027 close, and any additional national security awards as the three signals that this re-rating still has legs. If those keep landing, this pullback will look more like a reset than a breakdown.
That also means RKLB is not a stock to treat casually. The valuation is rich, profitability is still negative, and the chart is damaged, so this is a conviction growth name rather than a sleepy compounder. Even so, our take is straightforward: if the thesis is that Rocket Lab is becoming a defense and space infrastructure company, this drop looks like a gift, not a red flag.
